ROCK抑制剂奈他舒地尔对TNF诱导的视神经变性中轴突的保护作用与AMPK-自噬通路相关
本研究在大鼠玻璃体内注射TNF或TNF联合奈他舒地尔,发现奈他舒地尔可显著保护TNF诱导的轴突变性,增加轴突内自噬体数量,上调视神经LC3-II和p-AMPK水平,并改善TNF诱导的p62升高。AMPK激活剂A769662也表现出轴突保护作用,而AMPK抑制剂多索吗啡可显著抑制奈他舒地尔的轴突保护作用,提示其保护作用可能与上调p-AMPK相关。
要点
- 奈他舒地尔可显著减轻TNF诱导的大鼠视神经轴突变性。
- 奈他舒地尔上调视神经p-AMPK和LC3-II水平,并改善TNF诱导的p62升高。
- AMPK抑制剂多索吗啡显著抑制奈他舒地尔的轴突保护作用。
核心结论
- 奈他舒地尔上调p-AMPK和自噬,其介导的轴突保护作用可能与上调p-AMPK相关。
研究设计与样本
- 在大鼠玻璃体内注射TNF或TNF联合奈他舒地尔,进行轴突数量定量、电子显微镜观察自噬体、免疫组化检测p-AMPK定位及免疫印迹分析p62、LC3-II和p-AMPK水平。
- 评估AMPK激活剂A769662或AMPK抑制剂多索吗啡对轴突数量的影响。
主要发现
- 形态学分析显示奈他舒地尔对TNF诱导的轴突变性有明显保护作用。
- 奈他舒地尔增加轴突内自噬体数量。
- 奈他舒地尔在TNF处理眼和对照眼中均显著上调视神经LC3-II水平。
- TNF诱导的p62蛋白水平升高被奈他舒尔显著改善,单用奈他舒地尔降低p62水平。
- 奈他舒地尔显著上调视神经p-AMPK水平;A769662表现出明显的轴突保护作用,上调LC3-II水平并显著改善TNF诱导的p62升高;免疫组化显示p-AMPK存在于轴突中;多索吗啡显著抑制奈他舒地尔介导的轴突保护作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Netarsudil, a Rho kinase inhibitor with norepinephrine transport inhibitory effect, lowers intraocular pressure, however, its effect on axon damage remains to be elucidated. The aim of the current study was to investigate the effect of netarsudil on TNF-induced axon loss and to examine whether it affects phosphorylated-AMP-activated kinase (p-AMPK) and autophagy in the optic nerve. METHODS: Intravitreal administration of TNF or TNF with netarsudil was carried out on rats and quantification of axon number was determined. Electron microscopy determined autophagosome numbers. Localization of p-AMPK expression was examined by immunohistochemistry. The changes in p62, LC3-II, and p-AMPK levels were estimated in the optic nerve by immunoblot analysis. The effect of an AMPK activator A769662 or an AMPK inhibitor dorsomorphin on axon number was evaluated. RESULTS: Morphometric analysis revealed apparent protection by netarsudil against TNF-induced axon degeneration. Netarsudil increased autophagosome numbers inside axons. Netarsudil treatment significantly upregulated optic nerve LC3-II levels in both the TNF-treated eyes and the control eyes. Increased p62 protein level induced by TNF was significantly ameliorated by netarsudil. The netarsudil administration alone lessened p62 levels. Netarsudil significantly upregulated the optic nerve p-AMPK levels. A769662 exhibited obvious axonal protection against TNF-induced damage. A769662 treatment upregulated LC3-II levels and the increment of p62 level induced by TNF was significantly ameliorated by A769662. Immunohistochemical analysis revealed that p-AMPK is present in axons. Netarsudil-mediated axonal protection was significantly suppressed by dorsomorphin administration. CONCLUSIONS: Netarsudil upregulated p-AMPK and autophagy. Netarsudil-mediated axonal protection may be associated with upregulated p-AMPK.
引用
- Kitaoka Y, Sase K, Tsukahara C, et al. Axonal Protection by Netarsudil, a ROCK Inhibitor, Is Linked to an AMPK-Autophagy Pathway in TNF-Induced Optic Nerve Degeneration. Invest Ophthalmol Vis Sci. 2022. PMID: 34982146. doi:10.1167/iovs.63.1.4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。